Compugen to Present at the JMP Securities Life Sciences Conference May 9, 2023 07:00AM
Compugen to Participate in the JMP Securities C-Suite Series- TIGIT Landscape Overview Jan 23, 2023 07:00AM
Compugen to Participate in the JMP Securities Hematology and Oncology Summit Nov 29, 2022 07:00AM
Compugen to Present at Upcoming Investor Conferences Jun 1, 2022 07:00AM
Compugen to Present at Upcoming Investor Conferences Nov 8, 2021 07:00AM


May 26, 2020 06:24AM JMP Securities Resumes Compugen (CGEN) at Market Outperform
Jun 15, 2018 07:06AM Compugen (CGEN) Prices 5.3M Share Registered Direct Offering at $3.95/Sh
Jun 15, 2018 07:00AM Compugen Announces $21 Million Registered Direct Offering of Ordinary Shares and Warrants
May 23, 2017 07:00AM Compugen to Present at Two Upcoming Investor Conferences in June
Jun 22, 2016 07:09AM Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program
Jun 15, 2016 07:00AM Compugen to Present at JMP Securities Life Sciences Conference in New York
Jun 15, 2015 07:00AM Compugen to Present at JMP Securities Life Sciences Conference in New York
Jun 18, 2014 06:43AM JMP Securities Starts Compugen (CGEN) at Market Outperform
Feb 28, 2014 09:16AM Compugen (CGEN) Prices 6M Offering at $10.50/Share